Max N. Dawson

Max Dawson has 20 years of industry experience, most recently as Vice President of Finance and Operations at Pellepharm; responsible for finance, operations, and human resources.

Over his career, he has led and participated in over 50 licensing transactions and over $125m in debt and equity financings.

Max was formerly Vice President and Head of Business Development and Global Licensing at Adagene; previously, he was was a member of the business development team at Dyax Corp, and the finance team at Vertex and Merck Serono (formerly Merck KGaA).

He started his career as a bench scientist in the biochemistry group at Vertex Pharmaceuticals.

Mr. Dawson holds an MBA from the F.W. Olin school of business, where he has also guest lectured. He earned his undergraduate degree, with honors, from Bates College in Lewiston Maine.